TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.240
+0.120 (10.71%)
At close: Mar 9, 2026, 4:00 PM EDT
1.220
-0.020 (-1.61%)
After-hours: Mar 9, 2026, 7:27 PM EDT
TScan Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -129.77 | -127.5 | -89.22 | -66.22 | -48.63 | |
| Depreciation & Amortization | 2.87 | 4.11 | 5.36 | 5.14 | 3.33 | |
| Loss (Gain) From Sale of Investments | -2.41 | -3.9 | -1.07 | - | - | |
| Stock-Based Compensation | 11.71 | 9.55 | 5.21 | 4.55 | 2.52 | |
| Other Operating Activities | 0.46 | 1.86 | 0.76 | 0.26 | - | |
| Change in Accounts Payable | -3.01 | 1.99 | -0.05 | 0.53 | 0.01 | |
| Change in Unearned Revenue | -10.33 | -2.82 | 11.89 | -9.03 | -6.54 | |
| Change in Other Net Operating Assets | -4.84 | 5.88 | 5.77 | -1.73 | 0.63 | |
| Operating Cash Flow | -135.32 | -110.82 | -61.36 | -66.5 | -48.68 | |
| Capital Expenditures | -4.41 | -3.83 | -3.15 | -4.23 | -9.94 | |
| Investment in Securities | 113.78 | -48.79 | -57.61 | - | - | |
| Investing Cash Flow | 109.37 | -52.61 | -60.76 | -4.23 | -9.94 | |
| Long-Term Debt Issued | - | 32.46 | - | 29.35 | - | |
| Long-Term Debt Repaid | - | -17.14 | - | - | - | |
| Net Debt Issued (Repaid) | - | 15.31 | - | 29.35 | - | |
| Issuance of Common Stock | 0.26 | 35.18 | 43.13 | 0.33 | 89.94 | |
| Other Financing Activities | -0.6 | 158.27 | 92.32 | -0.32 | - | |
| Financing Cash Flow | -0.34 | 208.77 | 135.44 | 29.36 | 189.67 | |
| Net Cash Flow | -26.28 | 45.33 | 13.33 | -41.37 | 131.05 | |
| Free Cash Flow | -139.73 | -114.65 | -64.5 | -70.73 | -58.62 | |
| Free Cash Flow Margin | -1353.28% | -4071.27% | -306.45% | -522.56% | -578.03% | |
| Free Cash Flow Per Share | -1.08 | -1.02 | -1.35 | -2.94 | -5.03 | |
| Cash Interest Paid | 2.31 | 2.88 | 3 | 0.66 | - | |
| Levered Free Cash Flow | -97.25 | -68.97 | -41.83 | -42.84 | -33.43 | |
| Unlevered Free Cash Flow | -95.52 | -66.69 | -39.48 | -42.1 | -33.43 | |
| Change in Working Capital | -18.18 | 5.05 | 17.61 | -10.23 | -5.9 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.